ArticleCancers2024
Osteosarcoma Arising as a Secondary Malignancy following Treatment for Hematologic Cancer: A Report of 33 Affected Patients from the Cooperative Osteosarcoma Study Group (COSS).
Stefan S Bielack et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.